3/A

OWNERSHIP DOCUMENT

Company: Oruka Therapeutics, Inc.
Filed: April 7, 2022
Period of Report: April 1, 2022
Accession Number: 0000921895-22-001176

View Document ↗ View on SEC.gov ↗